Modelling the epidemiological impact of scaling up HIV testing and antiretroviral treatment in China.

@article{Zhang2012ModellingTE,
  title={Modelling the epidemiological impact of scaling up HIV testing and antiretroviral treatment in China.},
  author={Lei Zhang and Richard T Gray and David P. Wilson},
  journal={Sexual health},
  year={2012},
  volume={9 3},
  pages={
          261-71
        }
}
BACKGROUND The HIV epidemic in China has been increasing. In response, a 5-year action plan in China has prioritised the scale-up of HIV testing and treatment. METHODS We use a mathematical model to reproduce HIV epidemic trends in China and to forecast epidemic trends according to current conditions or increases in the rate of HIV testing or roll-out of antiretroviral therapy. RESULTS We show that the epidemic in China could be expected to experience a 2.5-fold expansion over the next 5… 
View on PubMed
publish.csiro.au
27 Citations
Highly Influential Citations
1
Background Citations
11
Methods Citations
3

27 Citations

Citation Type

Citation Type

Mathematical modelling of the impact of testing, treatment and control of HIV transmission in Kenya
TLDR
A deterministic model is employed to provide a quantification of HIV prevention, testing and treatment with ART as public health measurements in the fight against HIV infection and the results show that the combination of several control mechanisms would significantly reduce the spread of the disease.
HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.
TLDR
An overall decrease of HIV prevalence is now observed in several key Asian countries due to effective prevention programs, and vaccines designed to induce broadly neutralizing antibodies and cell-mediated immune responses of greater breadth and depth in the mucosal compartments should be considered for testing in MSM and TG.
Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China
TLDR
The transmission model suggests that Beijing MSM will have a rapidly rising HIV epidemic, and even enhanced levels of TLC/ART will not interrupt epidemic expansion, despite optimistic assumptions for coverage.
Antiretroviral therapy for prevention of HIV transmission: implications for Europe.
TLDR
There remains a lack of strong evidence of clinical benefit for HIV-positive individuals starting ART with CD4 count above 350 cells/mm3, and a main goal of ART provision should be to increase ART coverage for all those in need.
Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region.
TLDR
It is made the case that TasP and PrEP implementation research in Asia is much needed to provide insights into the feasibility of these interventions in populations where firm evidence of 'real world' effectiveness is still lacking.
Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time between HIV Diagnosis and Antiretroviral Therapy Initiation Leads to Poor Treatment Adherence and Outcomes
TLDR
Long pretreatment waiting time in PLHIV can lead to higher risk of poor treatment adherence and HIV-related mortality, and current treatment guidelines should be updated to provide ART promptly.
HIV Treatment as Prevention: Contradictory Perspectives from Dynamic Mathematical Models
TLDR
This paper reviewed dynamic mathematical models to ascertain the complex effects of ART on HIV transmission and discusses more conservative inputs and outcomes relative to antiretroviral use in HIV infections inynamic mathematical models.
Increased HIV Testing among Men Who Have Sex with Men from 2008 to 2012, Nanjing, China
TLDR
HIV testing uptake more than doubled among MSM in Nanjing from 2008 to 2012 –a period of massive promotion and scale up of testing programs for MSM, but additional efforts are still needed to further increase the proportion of men being not only tested but also undergoing repeat testing if they engage in continued risk taking behavior.
Modelling in concentrated epidemics: informing epidemic trajectories and assessing prevention approaches
TLDR
This review summarizes recent mathematical modelling studies conducted among key populations including MSM, people who inject drugs, and female sex workers in low prevalence settings used as a marker of concentrated epidemics to optimize combination prevention focusing on key populations in different settings.
HIV and hepatitis C virus test uptake at methadone clinics in Southern China: opportunities for expanding detection of bloodborne infections
TLDR
Methadone clinics provide an opportunity for routine integrated HIV and HCV screening among drug users in China and Increased test uptake in young drug users and increased health care personnel at clinics may further improve screening.
...
1
2
3
...

References

SHOWING 1-10 OF 100 REFERENCES
The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models.
TLDR
It is predicted that (over the next decade) in Africa, the impact of ART on reducing HIV transmission (and prevalence) is likely to be undetectable (unless accompanied by substantial changes in behavior), and large-scale surveillance for detecting transmitted resistance in Africa is unnecessary.
Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: The effect of the urban–rural divide
TLDR
Predicting the epidemiological impact of drug allocation strategies (DAS) by using a spatially explicit model that links urban and rural epidemics, it is found that a Durban-only DAS would generate the lowest levels of transmitted resistance.
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
Overview of the HIV/AIDS epidemic, scientific research and government responses in China
TLDR
The Chinese government has taken bold steps to scale-up HIV testing and counseling, offer free anti-retroviral treatment to AIDS patients, and expand primary prevention measures such as methadone maintenance and needle exchange programs for drug users and condom promotion for sex workers and men who have sex with men.
Epidemiology of HIV in China
The first case of AIDS in China was diagnosed in 1985, heralding the HIV epidemic in mainland China. As of 30 September 2001 the Chinese Ministry of Health reported a total of 28 133 people infected…
The Chinese free antiretroviral treatment program: challenges and responses.
TLDR
The Free ART Program has made considerable progress in providing the necessary care and treatment for HIV-infected people in China and has strong government support for continued improvement and expansion.
Estimating the number of people at risk for and living with HIV in China in 2005: methods and results
TLDR
The number of people exposed to HIV in China, the number living with HIV, and the number of new HIV infections and deaths in 2005 are used to make new estimates based on a much wider range of surveillance data as well as mass screening of former plasma donors.
Risk of HIV/AIDS in China: subpopulations of special importance
TLDR
Though commercial sex workers have contributed to a small proportion of the reported epidemic thus far, flourishing commercial sex is of growing concern and may have a bridging role in transmitting HIV from core groups to the general population.
HIV/AIDS epidemiology and prevention in China.
TLDR
The overall HIV/AIDS epidemic is at a low level (0.05%) and concentrated in several at risk populations, however, the data show that new cases of HIV infection are growing every year and spreading from atrisk populations to the general population.
Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men.
TLDR
Promoting increases in the coverage and frequency of testing for HIV could be a highly-effective public health intervention, but the population-level impact of interventions based on promoting early treatment of patients diagnosed in primary HIV infection (PHI) is likely to be small.
...
1
2
3
4
5
...